Quartic.ai, a manufacturing AI and IIoT platform supplier, and Bright Path Laboratories, a provider of continuous flow reactor technologies, have signed an agreement to develop an AI-powered continuous manufacturing platform for active pharmaceutical ingredients (APIs) and other small molecule drugs using Bright Path Labs’ continuous bioreactor and the Quartic.ai smart manufacturing technology.   The U.S. imports approximately 72% of its APIs used in domestic pharmaceutical production from forei...